Electronics Production | April 30, 2009
Plexus post $389 million in revenue in Q2
Plexus has announced its Q2 Fiscal 2009 results. Revenue: $389 million, relative to guidance of $375 to $405 million. Restructuring and goodwill impairment charges of approximately $8.0 million.
Dean Foate, President and CEO, commented, "We are pleased to have delivered revenues at the mid-point of our guidance range and non-GAAP diluted EPS above the high end of our guidance range. As expected, overall revenues declined 15% sequentially from the fiscal first quarter with all sectors declining sequentially. While our fiscal second quarter was as challenging as expected, we have cause for cautious optimism. During our monthly forecast cycle in April we experienced a modest uptick in our full-year fiscal 2009 forecast for the first time in eight months. This improvement was due in part to forecast stabilization with some of our legacy customer programs, as well as the revenue forecasted with our many recent program wins. While it would be a stretch to call the results of one forecast cycle a trend, we are encouraged that we may be experiencing the demand trough. Additionally, our business development teams continue to leverage the strength of our brand in the EMS market, turning in another exceptional quarter with 21 new program wins that we currently anticipate will generate approximately $220 million in annualized revenue when the programs are fully ramped in production over the coming quarters, subject to risks around the timing and ultimate realization of the forecasted revenues. We believe we are gaining market share." Mr. Foate continued, "We are establishing fiscal third quarter 2009 revenue guidance of $355 to $385 million with diluted EPS of $0.18 to $0.25, excluding any restructuring charges and including approximately $0.04 per share of stock-based compensation expense. Our guidance suggests that we will likely see another quarter with a sequential decline in revenue, although we currently expect the percentage decline to be moderate when compared to the decline in the fiscal second quarter. Despite this relative optimism, the fiscal third quarter could still be quite challenging and we are not immune to the difficulties our customers may experience in their end markets as well as the overall economic conditions." Ginger Jones, Vice President and CFO, commented, "Our diluted EPS was impacted by four significant items. As previously announced, we recognized approximately $8.0 million of pre-tax restructuring and non-cash goodwill impairment charges resulting in a negative $0.18 EPS impact. Offsetting these charges were three positive impacts to diluted EPS. First, we recognized a $1.4 million benefit from a discrete tax adjustment during the quarter delivering a $0.03 benefit. Second, as a consequence of aggressive cost reductions, our selling & administrative ("S&A") expenses were $2.0 million lower than earlier expectations, delivering a $0.05 benefit. Third, our tax rate for fiscal 2009 is now estimated to be 7%, before the discrete tax adjustment, due to lower forecasted earnings in higher tax jurisdictions. This is lower than the 10% tax rate used when we established our guidance for this quarter; consequently, diluted EPS for the quarter reflects a $0.02 benefit. The total of these three positive items reflects a net increase of $0.10 per share. As compared to our fiscal second quarter non-GAAP diluted EPS guidance, excluding the $0.15 associated with the restructuring and non-cash goodwill impairment charges as well as the discrete tax adjustment, we achieved non-GAAP diluted EPS of $0.28, which is above the high end of our guidance range." Ms. Jones continued, "We have moved aggressively to remove costs from the business over the quarter. We ceased operations as planned at our Ayer, Massachusetts facility in March 2009. We also reduced our workforce in our North American manufacturing operations, which includes our site in Juarez, Mexico, totaling approximately 17 percent of North American operations headcount. Turning to S&A expense, we have completed reductions in workforce totaling approximately 10 percent of that headcount." Ms. Jones concluded, "Looking forward to the fiscal third quarter, we do not currently anticipate any further significant restructuring. We have identified other cost-cutting measures that could be implemented quickly if forecasted revenues decline further or market conditions worsen. We feel we have struck the proper balance of cost management and modest investments to support our many new program wins as well as our long-term growth strategy."
Royal Flex Circuits boosts effort to support healthcare Santa Fe Springs, California-based Royal Flex Circuits is ramping up capacity at its year-old manufacturing facility to be produce more of the printed circuits needed in the production of ventilators used specifically in the treatment of Coronavirus.
Lam Research reacts to COVID-19 situation Fremont, California-based Lam Research Corporation has issued a business update for its quarter ending March 31, 2020.
Panasonic,Tesla scaling down production in Nevada In response to Panasonic’s announcement this week of a temporary, full suspension of production of its operations at Tesla’s Gigafactory in Nevada, Tesla also issued a statement that it would significantly decrease production at the site.
NOTE temporarily suspends production at Windsor plant Swedish EMS provider NOTE has, in line with the UK authorities' decision to limit all non-essential travel and work, temporarily halted its production at its manufacturing facility in Windsor.
Texas Instruments adjusting operations in Texas Texas Instruments is following a Dallas County shelter-in-place order and reducing operations at the company’s Dallas-area plants.
European EV battery production gets a boost from the EIB The European Investment Bank (EIB) has signed a EUR 480 million loan agreement with LG Chem Wroclaw Energy, the Polish subsidiary of the LG Chem Group that was established to develop the group’s battery production facility in Europe.
Würth Elektronik CBT produces PCBs for ventilators The worldwide spread of the coronavirus is not only increasing the demand for personal protective equipment, but also for medical ventilators.
North American PCB industry sales down 1.1% in February Total North American PCB shipments in February 2020 were down 1.1% compared to the same month last year.
U.S. may further crimp Huawei's global chip supply Senior Trump administration officials have reportedly agreed on new restrictions to curb the global supply of chips to China’s Huawei Technologies, sources are saying.
Tesla to reopen NY plant to make ventilators Tesla has joined industry efforts to shift production from autos and other non-healthcare related components to much needed supplies that support the domestic battle against rising numbers of coronavirus victims and the need for testing.
Bosch develops rapid test for COVID-19 Developed in just six weeks, Bosch says the rapid test can detect a COVID-19 infection in patients in under two and a half hours – measured from the time the sample is taken to the time the result arrives.
Lockdown in India halts production at Foxconn and Wistron Both EMS giants are complying with the nationwide lockdown ordered by Prime minister Narendra Modi. Both Foxconn and Wistron have now suspended production at their plants in India.
NAND Flash ASP may tumble in 2H20 ahead of expectations The continued spread of the COVID-19 pandemic has resulted in considerably weakened shipment for most end products in 1Q20, according to the DRAMeXchange research division of TrendForce,
Beijer Electronics takes preventive measures – downsizes workforce Beijer Group says it has increased its readiness and is taking measures to address the currently assessed consequences of the spread of COVID-19.
COVID-19 forces Lacroix to close several plants The French EMS provider says it is taking appropriate steps to limit the spread of COVID-19, safeguard its teams and, as far as possible, ensure business continuity for its customers.
PVA joins growing list of companies helping fight COVID-19 Upstate New York-based PVA has ramped up efforts to supply solutions for the shortage of COVID-19 test kits, portable respirators, and mechanical ventilators.
Applied Materials walks back Q2FY20 business outlook Applied Materials Inc. is withdrawing its business outlook for the second quarter of fiscal 2020, ending on April 26, 2020, due to the changing worldwide response to COVID-19 and its impact on the company’s supply chain and manufacturing operations.
Getting creative: Ford, 3M, GE, UAW unite to battle COVID Ford Motor Company, 3M and GE Healthcare are brainstorming ways to engineer and manufacture medical equipment and supplies for front line healthcare workers and responders, as well as patients fighting coronavirus.
Hamamatsu Photonics establishes subsidiary in Korea Hamamatsu Photonics Korea Co., Ltd. has been established as a subsidiary to strengthen the sales structure for its Imaging and Measurement Instruments business in South Korea.
Serial production & prototype construction continues at Akasol Akasol says it will maintain its serial production as well as prototype and sample construction for the time being, despite the current crisis related to COVID-19; but with stricter precautions related to health and safety.
Bittium receives purchase order from the Finnish Defence Forces Bittium has received a purchase order from the Finnish Defence Forces for the Bittium Tactical Wireless IP Network (TAC WIN) system's products, which are meant for tactical communications.
Italian restrictions creates uncertainties for GPV’s Swiss factory As of the March 23, GPV’s production site in Mendrisio is unable to operate due to further restrictions imposed by the Italian government as well as from the government of the canton Ticino in Switzerland in an attempt to combat the spread of COVID-19.
Incap temporarily reduces capacity in the UK Following new strict guidelines announced by the British government on Monday 24 March to contain the COVID-19 pandemic in the UK, Incap will temporarily reduce the operations of its Straffordshire factory in the UK to focus on production of medical and scientific instruments only.
II-VI ups capacity for diagnostic testing systems II-VI Incorporated, a provider of lasers, optics, thermoelectrics, and subassemblies for the life sciences market, is ramping up manufacturing capacity of components and subassemblies for molecular diagnostic testing systems for polymerase chain reaction (PCR) testing platforms.Load more news